Menu

As a future-oriented company,
botiss biomaterials invests substantially in cutting-edge research such as

stem cells and growth factors.

 

We are convinced that the investigation of the interaction between biomaterials and stem cells and/or signaling proteins may pave the way for new approaches to develop innovative technologies and products. Therefore our worldwide cooperation with prominent research centers and key opinion leaders gives further impulse for pioneering clinical solutions and trends in the field of tissue regeneration. Our innovative technologies are founded on longstanding academic and industrial research and testing.

more than

100

ongoing STUDIES carried out in national and international research centers

clinical and scientific collaboration with about

75

universities and research institutions around the world

more than

300

clinical and scientific contributions